PUBLIC COMPANY
save$GNPXGenprex, Inc.
$GNPXAustin, TX, USupdated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Preclinical1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer
- phase2Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
- phase2Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (2)
- Feb 27, 26tax coverConfer Ryan M. · President, CEO and CFO9,330 sh
- Feb 27, 26tax coverBerger Mark Stanley · Chief Medical Officer7,168 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that